QUICKLINKS AND VIEW OPITONS
Follow @fatnews
Prozac (fluoxetine) causes weight loss or slight weight gain after one year
Posted by .(JavaScript must be enabled to view this email address)
Monday, April 25, 2005 10:58 pm Email this article
Prozac (fluoxetine) can cause considerable weight loss or slight weight gain according to a analysis by the RAND Corporation. 9 studies
Their analysis included 9 studies.
Six out of seven studies that reported weight loss after six months, reported weight loss.
6 month weight loss: 2-20 lbs
The weight loss after six months varied in these studies from 2 to 20 pounds more than placebo.
1 year weight loss: 31.9 lbs to a weight gain of 0.8 lbs
The weight loss after one year varied from a weight loss of 31.9 pounds more than placebo, to a weight gain of 0.8 pounds more than placebo.
Comment: Depression can cause either an increase in appetite, which I believe is the most common by far, which, in my experience, is associated with stress, or a decrease in appetite, which, again, in my experience, is associated with exhaustion.
I assume that the weight loss seen in these studies mostly included people with a depression-induced increase in appetite.
Research has found that 5-HTP, which converts to serotonin in the body, is more effective at reducing stress-induced eating than at reducing hunger due to lack of food.
Therefore, I imagine that Prozac (fluoxetine) caused weight loss in these studies, not because it is such an effective appetite suppressant, but rather it reduced stress-induced or depression-induced eating, perhaps allowing people to lose weight that they had gained due to their stress/depression-induced eating.
Adverse effects
Adverse effects from Prozac included nervousness, sweating, and tremors with are 6.4 times more common than normal; nausea and vomiting which are 2.7 times more common than normal; fatigue, drowsiness, sleeping more than normal, and muscle weakness which is 2.4 times more common than normal; insomnia, 2.1 times more common than normal; and diarrhea which is 1.7 times more common than normal.
REFERENCE
Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman L, Hilton L, Suttorp M, Solomon V, Shekelle P, Morton S. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005 Apr 5, 142(7):532-46.
AUTHOR’S CONTACT INFORMATION
Southern California Evidence-Based Practice Center
RAND Health Division
1776 Main Street
Santa Monica, CA 90401-3208
Tel: 310-393-0411
Fax: 310-393-4818
Articles on the same subject can be found here:
COMMENTS
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.